S2Medical AB (publ) announces change of CFO

S2Medical AB (publ) has recruited a new Chief Financial Officer. Ingvild Thiry who comes from a deputy CEO position in the publicly listed company Hoylu AB will commence her employment as Chief Financial Officer latest during September of the current year. Ingvild will thereby be responsible for the financial reporting, financial management, ensuring that the economical operations are streamlined as well as ensuring that the economic resources in the company are managed in the best possible way.

This disclosure contains information that S2Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 08-06-2022 12:28 CET.

Contact Details
Petter Sivlér – CEO, S2Medical AB (publ)
Telephone: +46 (0)8-70 000 50
E-mail: petter.sivler@s2m.se

Certified Adviser
Vator Securities AB
Telephone +46 (0)8-580 065 99
Website: www.vatorsec.se 
E-mail: ca@vatorsec.se

About S2Medical 

S2Medical AB (publ) is a medical technology company that develops and sells innovative wound healing products for the entire wound healing process, with a focus on burns and chronic wounds. The company has developed eiratex®, a new cellulose-based material for healing severe burns and chronic wounds. The material heals wounds effectively and thereby reduces both suffering for patients and costs for health care.

Share's ticker: S2M

Share's ISIN-code: SE0011725084